• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨甲酰基百合碱衍生物逆转人结肠腺癌细胞多药耐药性的研究。

Lycorine Carbamate Derivatives for Reversing P-glycoprotein-Mediated Multidrug Resistance in Human Colon Adenocarcinoma Cells.

机构信息

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal.

Department of Medical Microbiology, Albert Szent-Györgyi Health Center, Faculty of Medicine, University of Szeged, Semmelweis utca 6, 6725 Szeged, Hungary.

出版信息

Int J Mol Sci. 2023 Jan 20;24(3):2061. doi: 10.3390/ijms24032061.

DOI:10.3390/ijms24032061
PMID:36768386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916770/
Abstract

Multidrug resistance (MDR) is a major challenge in cancer chemotherapy. Aiming at generating a small library of anticancer compounds for overcoming MDR, lycorine (), a major Amaryllidaceae alkaloid isolated from , was derivatized. Thirty-one new compounds (-) were obtained by chemical transformation of the hydroxyl groups of lycorine into mono- and di-carbamates. Compounds - were evaluated as MDR reversers, through the rhodamine-123 accumulation assay by flow cytometry and chemosensitivity assays, in resistant human colon adenocarcinoma cancer cells (Colo 320), overexpressing P-glycoprotein (P-gp, ABCB1). Significant inhibition of P-gp efflux activity was observed for the di-carbamate derivatives, mainly those containing aromatic substituents, at non-cytotoxic concentrations. Compound , bearing a benzyl substituent, and compounds and with phenethyl moieties, were among the most active, exhibiting strong inhibition at 2 µM, being more active than verapamil at 10-fold higher concentration. In drug combination assays, most compounds were able to synergize doxorubicin. Moreover, some derivatives showed a selective antiproliferative effect toward resistant cells, having a collateral sensitivity effect. In the ATPase assay, selected compounds (, , , , , and ) were shown to behave as inhibitors.

摘要

多药耐药性(MDR)是癌症化疗的主要挑战。为了生成克服 MDR 的抗癌化合物的小文库,我们对从石蒜属植物中分离得到的主要石蒜科生物碱石蒜碱()进行了衍生化。通过将石蒜碱的羟基化学转化为单-和二氨基甲酸酯,得到了 31 种新化合物(-)。通过流式细胞术测定罗丹明 123 积累实验和药敏实验,评估了化合物-作为多药耐药性逆转剂,用于表达 P 糖蛋白(P-gp,ABCB1)的人结肠直肠癌细胞(Colo 320)耐药株。在非细胞毒性浓度下,观察到二氨基甲酸酯衍生物对 P-gp 外排活性有显著抑制作用,主要是那些含有芳基取代基的衍生物。具有苄基取代基的化合物和含有苯乙基部分的化合物和,是最有效的化合物之一,在 2µM 时表现出强烈的抑制作用,在 10 倍更高浓度时比维拉帕米更有效。在药物联合实验中,大多数化合物能够协同增强阿霉素的作用。此外,一些衍生物对耐药细胞表现出选择性的增殖抑制作用,具有旁系敏感性效应。在 ATP 酶测定中,选定的化合物(、、、、、和)被证明是抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/9916770/4bc41008a63e/ijms-24-02061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/9916770/c7d265ac8bdd/ijms-24-02061-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/9916770/b51f5fd98c9f/ijms-24-02061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/9916770/4bc41008a63e/ijms-24-02061-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/9916770/c7d265ac8bdd/ijms-24-02061-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/9916770/b51f5fd98c9f/ijms-24-02061-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/9916770/4bc41008a63e/ijms-24-02061-g002.jpg

相似文献

1
Lycorine Carbamate Derivatives for Reversing P-glycoprotein-Mediated Multidrug Resistance in Human Colon Adenocarcinoma Cells.氨甲酰基百合碱衍生物逆转人结肠腺癌细胞多药耐药性的研究。
Int J Mol Sci. 2023 Jan 20;24(3):2061. doi: 10.3390/ijms24032061.
2
Lycorine and homolycorine derivatives for chemo-sensitizing resistant human ovarian adenocarcinoma cells.用于使耐药性人卵巢腺癌细胞化疗增敏的石蒜碱和高石蒜碱衍生物
Phytomedicine. 2024 Apr;126:155460. doi: 10.1016/j.phymed.2024.155460. Epub 2024 Feb 16.
3
Triterpenes from Momordica balsamina (African pumpkin): ABCB1 inhibition and synergistic interaction with doxorubicin in resistant cancer cells.来自苦瓜(非洲南瓜)的三萜类化合物:对耐药癌细胞中ABCB1的抑制作用以及与阿霉素的协同相互作用。
Phytochemistry. 2022 Nov;203:113354. doi: 10.1016/j.phytochem.2022.113354. Epub 2022 Aug 6.
4
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.调节 N,N-双(烷醇)胺芳基酯杂二聚体中的间隔基,发现了一系列强效基于 P-糖蛋白的多药耐药(MDR)调节剂。
Eur J Med Chem. 2019 Jun 15;172:71-94. doi: 10.1016/j.ejmech.2019.03.054. Epub 2019 Mar 27.
5
Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.吩噻嗪对结肠腺癌细胞ABCB1相关多药耐药性的逆转作用
Anticancer Res. 2015 Jun;35(6):3245-51.
6
Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer.探索单萜吲哚生物碱骨架以逆转癌症中P-糖蛋白介导的多药耐药性
Pharmaceuticals (Basel). 2021 Aug 28;14(9):862. doi: 10.3390/ph14090862.
7
Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells.烷基化单萜吲哚生物碱衍生物作为耐药癌细胞中有效的 P 糖蛋白抑制剂。
Eur J Med Chem. 2021 Jan 15;210:112985. doi: 10.1016/j.ejmech.2020.112985. Epub 2020 Nov 4.
8
Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.白桦脂酸 23-羟基衍生物逆转 HepG2/ADM 和 MCF-7/ADR 细胞的耐药性。
Anticancer Drugs. 2013 Jun;24(5):441-54. doi: 10.1097/CAD.0b013e32835fcc77.
9
New Chalcone Derivative Inhibits ABCB1 in Multidrug Resistant T-cell Lymphoma and Colon Adenocarcinoma Cells.新型查尔酮衍生物抑制多药耐药 T 细胞淋巴瘤和结肠腺癌细胞中的 ABCB1。
Anticancer Res. 2019 Dec;39(12):6499-6505. doi: 10.21873/anticanres.13864.
10
Reversal of P-glycoprotein-mediated multidrug resistance by natural N-alkylated indole alkaloid derivatives in KB-ChR-8-5 drug-resistant cancer cells.天然 N-烷基吲哚生物碱衍生物逆转 KB-ChR-8-5 耐药癌细胞中的 P-糖蛋白介导的多药耐药性。
J Biochem Mol Toxicol. 2023 Sep;37(9):e23421. doi: 10.1002/jbt.23421. Epub 2023 Jun 22.

引用本文的文献

1
Development of heterocyclic derivatives as P-glycoprotein inhibitors against multidrug resistance: pharmacological activities, structure-activity relationship and target (2020-2024).作为P-糖蛋白抑制剂用于对抗多药耐药性的杂环衍生物的开发:药理活性、构效关系及靶点(2020 - 2024年)
RSC Med Chem. 2025 Aug 26. doi: 10.1039/d5md00609k.
2
Synthesis and Transformations of Bioactive Scaffolds via Modified Mannich and aza-Friedel-Crafts Reactions.通过改良曼尼希反应和氮杂傅克反应合成生物活性支架及其转化
Chem Rec. 2025 Aug;25(8):e202500077. doi: 10.1002/tcr.202500077. Epub 2025 Jun 11.
3
Long noncoding RNA promotes 5-fluorouracil resistance in colorectal cancer by regulating miR-26b/p-glycoprotein axis.

本文引用的文献

1
Amaryllidaceae-Type Alkaloids from : Apoptosis-Inducing Effect and Cell Cycle Arrest on Triple-Negative Breast Cancer Cells.石蒜科生物碱:对三阴性乳腺癌细胞的凋亡诱导作用和细胞周期阻滞。
Molecules. 2022 Sep 6;27(18):5759. doi: 10.3390/molecules27185759.
2
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies.多药耐药性(MDR):药理学治疗中的普遍现象。
Molecules. 2022 Jan 18;27(3):616. doi: 10.3390/molecules27030616.
3
Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer.
长链非编码RNA通过调控miR-26b/p-糖蛋白轴促进结直肠癌对5-氟尿嘧啶的耐药性。
World J Gastrointest Oncol. 2025 May 15;17(5):102417. doi: 10.4251/wjgo.v17.i5.102417.
4
Synthesis of Tumor Selective Indole and 8-Hydroxyquinoline Skeleton Containing Di-, or Triarylmethanes with Improved Cytotoxic Activity.合成具有二芳基或三芳基甲烷的肿瘤选择性吲哚和 8-羟基喹啉骨架,提高细胞毒性活性。
Molecules. 2024 Sep 3;29(17):4176. doi: 10.3390/molecules29174176.
5
Nitrogen-containing andrographolide derivatives with multidrug resistance reversal effects in cancer cells.具有逆转癌细胞多药耐药作用的含氮穿心莲内酯衍生物。
RSC Med Chem. 2024 Feb 26;15(4):1348-1361. doi: 10.1039/d3md00711a. eCollection 2024 Apr 24.
6
Natural products reverse cancer multidrug resistance.天然产物可逆转癌症多药耐药性。
Front Pharmacol. 2024 Mar 8;15:1348076. doi: 10.3389/fphar.2024.1348076. eCollection 2024.
7
Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges.苯并吲哚里西啶生物碱娃儿藤碱和石蒜碱及其具有抗病毒、抗炎和抗癌特性的类似物:前景与挑战
Biomedicines. 2023 Sep 24;11(10):2619. doi: 10.3390/biomedicines11102619.
8
Natural Product-Derived Compounds for Targeting Multidrug Resistance in Cancer and Microorganisms.天然产物衍生化合物在靶向癌症和微生物多药耐药中的应用。
Int J Mol Sci. 2023 Sep 20;24(18):14321. doi: 10.3390/ijms241814321.
9
Indolo[2,3-]benzazocines and indolo[2,3-]benzazonines and their copper(II) complexes as microtubule destabilizing agents.吲哚并[2,3-]苯并氮杂卓和吲哚并[2,3-]苯并氮杂嗪及其铜(II)配合物作为微管去稳定剂。
Dalton Trans. 2023 Jul 25;52(29):9964-9982. doi: 10.1039/d3dt01632c.
探索单萜吲哚生物碱骨架以逆转癌症中P-糖蛋白介导的多药耐药性
Pharmaceuticals (Basel). 2021 Aug 28;14(9):862. doi: 10.3390/ph14090862.
4
Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance.与抗癌药物耐药性相关的临床ABC转运蛋白
Front Pharmacol. 2021 Apr 19;12:648407. doi: 10.3389/fphar.2021.648407. eCollection 2021.
5
BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancer.BBIT20 通过破坏乳腺癌和卵巢癌中 BRCA1-BARD1 相互作用来抑制同源 DNA 修复。
Br J Pharmacol. 2021 Sep;178(18):3627-3647. doi: 10.1111/bph.15506. Epub 2021 Jun 11.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells.烷基化单萜吲哚生物碱衍生物作为耐药癌细胞中有效的 P 糖蛋白抑制剂。
Eur J Med Chem. 2021 Jan 15;210:112985. doi: 10.1016/j.ejmech.2020.112985. Epub 2020 Nov 4.
8
Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer.含氮柚皮素衍生物逆转肿瘤多药耐药性的研究进展
Bioorg Med Chem. 2020 Dec 1;28(23):115798. doi: 10.1016/j.bmc.2020.115798. Epub 2020 Oct 4.
9
Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer.环氧赖百当烷衍生物作为用于消除癌症多药耐药性的MDR选择性化合物
Front Pharmacol. 2020 May 8;11:599. doi: 10.3389/fphar.2020.00599. eCollection 2020.
10
Mechanisms of Multidrug Resistance in Cancer Chemotherapy.癌症化疗中的多药耐药机制。
Int J Mol Sci. 2020 May 2;21(9):3233. doi: 10.3390/ijms21093233.